{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:27:23Z","timestamp":1776068843895,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Thyroid dysfunction, including non-thyroidal illness syndrome (NTIS), is commonly observed in critically ill patients and has been reported in COVID-19, particularly in those with severe disease. NTIS is defined by low free triiodothyronine (fT3) with normal or low thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels. Thyroid autoantibodies may also reflect immune system activation. The relationship between thyroid hormone alterations, autoimmunity, and clinical severity in COVID-19 remains incompletely understood. Methods: We conducted a retrospective study of 276 patients hospitalized with COVID-19, including 138 in the intensive care unit (ICU) and 138 in general wards. A control group of 110 hospitalized, non-infected patients was also analyzed. Serum concentrations of TSH, fT3, fT4 and reverse T3 (rT3) were measured. The presence of anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-Tg), and thyrotropin receptor antibodies (TRAb) was assessed. Results: NTIS was observed in 44.2% of ICU patients, 18.1% of non-ICU patients, and 1.8% of controls. The fT3\/rT3 ratio was lowest in ICU patients (median 0.11 vs. 0.16 in non-ICU and 0.22 in controls). Thyroid autoantibodies were significantly more prevalent in COVID-19 patients than in controls, with anti-TPO antibodies being the most frequently detected. Their presence, even in patients without known thyroid disease, may reflect immune activation associated with SARS-CoV-2 infection. Conclusions: NTIS and thyroid autoimmunity are frequent in hospitalized COVID-19 patients and may reflect disease severity and immune activation. Our study highlights the prognostic relevance of routine thyroid testing, including the fT3\/rT3 ratio and combined autoantibody positivity (notably the triple-positive pattern), by directly comparing ICU and non-ICU patients with a non-COVID control group.<\/jats:p>","DOI":"10.3390\/jcm14196784","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:48:05Z","timestamp":1758808085000},"page":"6784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non-Thyroidal Illness Syndrome and Thyroid Autoimmunity in Hospitalized COVID-19 Patients: A Retrospective Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9566-3039","authenticated-orcid":false,"given":"Ewa","family":"Koz\u0142owska","sequence":"first","affiliation":[{"name":"Central Laboratory, Central Teaching Hospital of University Clinical Center, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-749X","authenticated-orcid":false,"given":"Milena","family":"Ma\u0142ecka-Gie\u0142dowska","sequence":"additional","affiliation":[{"name":"Central Laboratory, Central Teaching Hospital of University Clinical Center, Medical University of Warsaw, 02-097 Warsaw, Poland"},{"name":"Department of Laboratory Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-4076","authenticated-orcid":false,"given":"Olga","family":"Ciepiela","sequence":"additional","affiliation":[{"name":"Central Laboratory, Central Teaching Hospital of University Clinical Center, Medical University of Warsaw, 02-097 Warsaw, Poland"},{"name":"Department of Laboratory Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Panesar, A., Gharanei, P., Khovanova, N., Young, L., and Grammatopoulos, D. (2024). Thyroid function during COVID-19 and post-COVID complications in adults: A systematic review. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1477389"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.27292","article-title":"Autoimmune complications of COVID-19","volume":"94","author":"Yazdanpanah","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Darvishi, M., Nazer, M.R., Shahali, H., and Nouri, M. (2022). Association of thyroid dysfunction and COVID-19: A systematic review and meta-analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.947594"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s40618-020-01482-4","article-title":"An update on non-thyroidal illness syndrome","volume":"44","author":"Fliers","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ashrafi, S., Hatami, H., Bidhendi-Yarandi, R., and Panahi, M.H. (2024). The prevalence of thyroid disorders in COVID-19 patients: A systematic review and meta-analysis. BMC Endocr Disord., 24.","DOI":"10.1186\/s12902-023-01534-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/1744666X.2021.1932467","article-title":"SARS-CoV-2-related immune-inflammatory thyroid disorders: Facts and perspectives","volume":"17","author":"Ruggeri","year":"2021","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1210\/clinem\/dgaa813","article-title":"Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19","volume":"106","author":"Lui","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","first-page":"473","article-title":"Thyrotoxicosis in patients with COVID-19 (THYRCOV study)","volume":"68","author":"Lania","year":"2020","journal-title":"Endocrine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/a-1804-9561","article-title":"Subacute thyroiditis following SARS-CoV-2 vaccines: Six cases report and review of the literature","volume":"54","author":"Kurtulmus","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00296-022-05106-3","article-title":"Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: A case series and literature review","volume":"42","author":"Freund","year":"2022","journal-title":"Rheumatol. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41584-021-00608-z","article-title":"Systemic and organ-specific immune-related manifestations of COVID-19","volume":"17","author":"Mariette","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/1744666X.2022.2085561","article-title":"Is post-COVID syndrome an autoimmune disease?","volume":"18","author":"Anaya","year":"2022","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1515\/cclm-2021-0805","article-title":"Low free-T3 serum levels and prognosis of COVID-19: Systematic review and meta-analysis","volume":"59","author":"Llamas","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/a-2014-4634","article-title":"Thyroid Function Abnormalities and Outcomes in Hospitalized Patients with COVID-19 Infection: A Cross-Sectional Study","volume":"55","author":"Patel","year":"2023","journal-title":"Horm. Metab. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41574-023-00946-w","article-title":"Thyroid dysfunction in COVID-19","volume":"20","author":"Lui","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhong, M., Gao, Y., Hu, H., Zhu, X., Gan, L., Li, L., Xiang, C., Yan, Y., and Dai, Z. (2023). Transient low T3 syndrome in patients with COVID-19: A new window for prediction of disease severity. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1154007"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fallahi, P., Elia, G., Ragusa, F., Paparo, S.R., Patrizio, A., Balestri, E., Mazzi, V., Benvenga, S., Varricchi, G., and Gragnani, L. (2023). Thyroid autoimmunity and SARS-CoV-2 infection. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196365"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sciacchitano, S., Capalbo, C., Napoli, C., Anibaldi, P., Salvati, V., De Vitis, C., Mancini, R., Coluzzi, F., and Rocco, M. (2022). Nonthyroidal Illness Syndrome: To Treat or Not to Treat? Have We Answered the Question? A Review of Metanalyses. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.850328"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Guo, J., Hong, Y., Wang, Z., and Li, Y. (2020). Prognostic Value of Thyroid Hormone FT3 in General Patients Admitted to the Intensive Care Unit. Biomed. Res Int., 2020.","DOI":"10.1155\/2020\/6329548"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sror-Turkel, O., El-Khatib, N., Sharabi-Nov, A., Avraham, Y., and Merchavy, S. (2024). Low TSH and low T3 hormone levels as a prognostic for mortality in COVID-19 intensive care patients. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1322487"},{"key":"ref_21","first-page":"902","article-title":"Thyroid hormone levels during hospital admission inform disease severity and mortality in COVID-19","volume":"31","author":"Carvalhal","year":"2021","journal-title":"Thyroid"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s40618-021-01599-0","article-title":"Thyroid dysfunction in COVID-19 patients","volume":"44","author":"Baldelli","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.36519\/idcm.2022.175","article-title":"Thyroid Dysfunction among the Patients with Critical COVID-19","volume":"4","year":"2022","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s40618-021-01554-z","article-title":"Thyroid and COVID-19: A review on pathophysiological, clinical and organizational aspects","volume":"44","author":"Lisco","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11154-020-09615-z","article-title":"Impact of COVID-19 on the thyroid gland: An update","volume":"22","author":"Scappaticcio","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1038\/s41467-024-53356-5","article-title":"Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19","volume":"15","author":"Jernbom","year":"2024","journal-title":"Nat Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40618-020-01436-w","article-title":"Detection of SARS-CoV-2 receptor ACE-2 mRNA in thyroid cells: A clue for COVID-19-related subacute thyroiditis","volume":"44","author":"Rotondi","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rossini, A., Cassibba, S., Perticone, F., Benatti, S.V., Venturelli, S., Carioli, G., Ghirardi, A., Rizzi, M., Barbui, T., and Trevisan, R. (2023). Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1126683"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0300060514562487","article-title":"The association between thyroid autoantibodies in serum and abnormal function and structure of the thyroid","volume":"43","author":"Yan","year":"2015","journal-title":"J. Int. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"bvab076","DOI":"10.1210\/jendso\/bvab076","article-title":"COVID-19 and Thyroid Diseases: A Bidirectional Impact","volume":"5","author":"Duntas","year":"2021","journal-title":"J Endocr Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","article-title":"SARS-CoV-2-related atypical thyroiditis","volume":"8","author":"Muller","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1210\/clinem\/dgaa830","article-title":"Thyroid function before, during, and after COVID-19","volume":"106","author":"Khoo","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tian, Y., Zhao, J., Wang, T., Wang, H., Yao, J., Wang, S., and Mou, Y. (2022). Thyroid diseases are associated with coronavirus disease 2019 infection: A systematic review and meta-analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.952049"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"03000605221082898","DOI":"10.1177\/03000605221082898","article-title":"Potential relationships between COVID-19 and the thyroid gland: An update","volume":"50","author":"Naguib","year":"2022","journal-title":"J. Int. Med. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:49:46Z","timestamp":1760035786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/19\/6784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jcm14196784"],"URL":"https:\/\/doi.org\/10.3390\/jcm14196784","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}